Judd W. Moul

PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer.

Lixia Xu, B G Stackhouse, Kelly Farina da Silva Florence et al. · PubMed · 2000 · 203 citations

Pathology, Tumor Biology, Genitourinary Cancer +16

Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer.

Judd W. Moul, William F. McCarthy, Eduardo B. Fernández et al. · PubMed · 1994 · 128 citations

Cancer Pathology, Vascular Invasion, Pathology +18

Infrequent <i>RAS</i> oncogene mutations in human prostate cancer

Judd W. Moul, Paul Friedrichs, Raymond S. Lance et al. · The Prostate · 1992 · 91 citations

Recombinant adenovirus vector expressing wildtype p53 is a potent inhibitor of prostate cancer cell proliferation

Shiv Srivastava, Dai Katayose, Yue Tong et al. · Urology · 1995 · 39 citations

Recombinant Adenovirus Vector, Potent Inhibitor, Gene Vector +8

Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen era

Edmond L. Paquette, Roger R. Connelly, Isabell A. Sesterhenn et al. · Cancer · 2001 · 30 citations · Full text